Ferozsons Laboratories Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, FEROZ's sales rose 28% to Rs 5.8bn, from Rs 4.5bn, and profit after tax rose 39% to Rs 354.0mn, from Rs 255.0mn (compared with Apr–Jun 2025).
Earnings per share were Rs 5.59, against Rs 4.74 a year earlier. The company reported a dividend of Rs 5.50 per share for the quarter.
At Rs 323.43, FEROZ trades at 16.4 times earnings.
- P/E ratio
- 16.4
- Dividend payout
- 98%
- of earnings
- Return on equity
- 8%
- Net margin
- 5.0%
- trailing twelve months
- Debt to equity
- 0.27
FEROZ quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 5.8bn | Rs 354.0mn | 6.1% | Rs 5.59 | Rs 5.50 |
| Jan–Mar 2026 | Rs 5.6bn | Rs 207.8mn | 3.7% | Rs 4.78 | — |
| Oct–Dec 2025 | Rs 6.7bn | Rs 344.0mn | 5.1% | Rs 6.19 | — |
| Jul–Sep 2025 | Rs 5.9bn | Rs 322.0mn | 5.4% | Rs 5.95 | — |
| Apr–Jun 2025 | Rs 4.5bn | Rs 255.0mn | 5.7% | Rs 4.74 | Rs 4.00 |
| Jan–Mar 2025 | Rs 5.1bn | Rs 248.0mn | 4.9% | Rs 4.59 | — |
| Oct–Dec 2024 | Rs 4.7bn | Rs 178.0mn | 3.8% | Rs 3.46 | — |
| Jul–Sep 2024 | Rs 4.5bn | Rs 241.0mn | 5.3% | Rs 5.07 | — |
FEROZ annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Jun 2026 | Rs 24.0bn | Rs 1.2bn | Rs 22.51 | Rs 5.50 |
| Year to Jun 2025 | Rs 18.9bn | Rs 922.0mn | Rs 17.86 | Rs 4.00 |
| Year to Jun 2024 | Rs 15.9bn | Rs 755.0mn | Rs 15.72 | Rs 3.00 |
| Year to Jun 2023 | Rs 11.5bn | Rs 297.0mn | Rs 6.24 | — |
| Year to Jun 2022 | Rs 9.3bn | Rs 790.0mn | Rs 16.90 | Rs 4.17 |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 25.9bn
- Shareholders' equity
- Rs 15.6bn
- Cash & bank
- Rs 642.1mn
- Total debt
- Rs 4.3bn
- Current ratio
- 1.87
- 3-month high
- Rs 415.91
- 3-month low
- Rs 318.57
- 1-month change
- -12.0%
- 3-month change
- -22.2%
Read more about FEROZ
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
FEROZ: common questions
What is FEROZ's share price?
Ferozsons Laboratories Ltd (FEROZ) last closed at Rs 323.43 on the Pakistan Stock Exchange.
Does FEROZ pay a dividend?
Yes. Ferozsons Laboratories Ltd paid Rs 5.50 per share for the year to Jun 2026.
What were FEROZ's latest results?
In the Apr–Jun 2026 quarter, FEROZ's sales rose 28% to Rs 5.8bn, from Rs 4.5bn, and profit after tax rose 39% to Rs 354.0mn, from Rs 255.0mn (compared with Apr–Jun 2025).
What is FEROZ's P/E ratio?
At Rs 323.43, FEROZ trades at 16.4 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.